Skip to main content
Georgia Cancer Info Logo
Donate
Georgia Cancer Info Logo
About Georgia CORENews & HappeningsWays to Give
Advancing ResearchExplore Clinical TrialsCollaboration Opportunities
ScreeningGeorgia Genetics ProgramEducation & NavigationSurvivorship

Check your hereditary breast & ovarian cancer risk with our easy Genetic Screening Tool.

Start risk assessment
Search ResourcesFind Cancer Centers
Donate
Georgia Cancer Info Logo

Contact us

+1-404-523-8735info@georgiacancerinfo.org
999 Peachtree St NE, Suite 400Atlanta, GA 30309

Sign up for news and announcements

  • Home
  • About
  • Contact
  • Facebook
  • LinkedIn
  • Instagram

© 2005 - 2026 Georgia Center for Oncology Research and Education. All Rights Reserved.

PrivacyTerms & Conditions
Rebecca Wallace, MMC
  1. About Us/
  2. Rebecca Wallace, MMC

Rebecca Wallace, MMC

Communications

Rebecca Wallace supports nonprofits that improve communities and the lives of the people that live in them. With nearly three decades of experience in cause campaigns and public-private initiatives, Rebecca has developed and implemented communications strategies for dozens of advocacy groups, chambers of commerce and state and local governments. Equipped with experience, a handful of amazing mentors, and the quick and nimble proficiency that comes with being a solo practitioner, she values becoming a member of the client’s team to provide clear, effective and strategic communications.

rebecca@rtwcommunications.com
Rebecca Wallace, MMC

Keep up to date with Georgia CORE on LinkedIn

Real stories from patients, survivors, and advocates across Georgia.

Follow on LinkedIn
Oct. stakeholder session: Should Georgia have a cancer clinical trials roundtable?

Day 2 of an impressive convening of Georgia CORE partners representing the cancer research, care provider, patient navigation and advocacy communities. Each stakeholder session was an opportunity for these groups to come together and discuss how to carry the recommendations forward of the Georgia House Study Committee on Access to Cancer Care on day 1; and the state of cancer clinical trials in Georgia on day 2. Be on the look out for the forthcoming report of these impactful two days!